8-KThe WireRoutine
Reg FD Disclosure
Filed Jan 27, 2025 · 1y ago · Accession 0001193125-25-012740
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Vanda Pharmaceuticals Inc.
- Ticker
- VNDA
- CIK
- 1347178
- Form type
- 8-K
- Filing date
- Jan 27, 2025
- Report date
- Jan 25, 2025
- Document
- d869105d8k.htm
- Size
- 181 KB